October 2026 FDA Recall Hydrocortisone Sodium Succinate by Zydus Pharmaceuticals (usa) Inc (D-0039-2027 - Failed Impurities/Degradation Specifications.)

This Class II drug recall was voluntarily initiated by Zydus Pharmaceuticals (usa) Inc on October 1, 2026 for the product Hydrocortisone Sodium Succinate. The FDA reported the reason for recall as failed impurities/degradation specifications.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0039-2027

Reason for Recall
Failed Impurities/Degradation Specifications.
Initiated
10-01-2026
Reported
10-21-2026
Quantity
70776 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Zydus Pharmaceuticals (USA) Inc
Nationwide within the United States
Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1907-1.

Batch or Lot Expiration Information

Lot# : LB00047A, LB00048A, Exp. Date 03/2028

Affected Packages Involved in this Recall